NEWS    RECALLS    COMPLAINT FORM    SCAM ALERTS   RESOURCES  
Small Claims Guide   Class Actions   Lemon Laws   FAQ   Newsletters  
Share


Complain about a product or service

Automotive    Education    Employment    Electronics    Family    Finance    Health    Homeowners    Insurance    Pets    Shopping    Travel     Print This     Email This    



NEWS   Latest |  Archives |  Auto |  Cells, etc. |  Computers |  Financial |  Health |  Homeowners |  Parents |  Privacy |  Scams |  Seniors |  Travel

Proposed Settlement Could Lower Prescription Drug Prices

Massachusetts court could approve class action agreement against wholesalers





September 23, 2008

Tablet Splitting: A Risky Practice
FDA Moves on Drug Counterfeiting
Bill Banning Drug "Pay-For-Delay" Gets Hearing
Drug Costs Rise Less Quickly, Study Finds
Coping With Costly Prescriptions
Proposed Settlement Could Lower Prescription Drug Prices
FDA: Baltimore Pharmacies Selling Expired and Counterfeit Drugs
Some Drug Prices Surging 100 Percent Or More
Kmart, Schnucks Expand Generic Rx Discounts
Coming Soon: Generic Drugs from China
Safeway Introduces Generic Drug Discounts
Medicaid Cuts 'Devastating,' Pharmacies Warn
Kroger Expands Its Generic Drug Discount Program
Supermarkets Launch Generic Drug Discount Programs
Drug Prices Can Vary Widely, Survey Finds
Wal-Mart Adds More Generic Drugs To Discount Plan
FDA Finds Problems with Online Drugs
Wal-Mart Expands $4 Generic Program
Walgreens.com's Pharmacy Gets Top Rating
Popular Blood Pressure Drug Goes Generic
Wal-Mart Expands Generic Drug Plan
Consumers Get Little Drug Price Information From Their Doctors
Florida Pharmacy Offers Generics Online for $3.79
Wal-Mart Adds 12 More States To $4 Drug Program
Wal-Mart Expands $4 Generic Drug Program To 14 More States
Report: Shopping Around Beats Medicare Drug Prices
Drugs by Mail: Money Saver or Rx for Disaster?
Wal-Mart Expands Its Generic Drug Discounts
Feds Give Up on Canadian Drug Crackdown
Target Matches Wal-Mart's $4 Generic Rx Price
Congress OKs Drug Shopping Trips To Canada
Seniors Bemoan "Donut Day"
Wal-Mart Cuts Generic Rx Prices To $4 In Florida
AARP: Drug Prices Still Rising
Illinois Sues 48 Drug Companies
Pharmacy Benefit Managers Scrutinized
Survey Shows Value of Comparison Shopping

A Massachusetts federal court decision could result in lower prescription drug prices for consumers and third party payers.

The U.S.District Court for the District of Massachusetts has given preliminary approval to the settlement of a class action against publishers of wholesale drug prices, and certified a separate class action against McKesson Corporation, a large drug wholesaler. The related lawsuits concern the pricing of more than 450 brand-name drugs.

First Databank ("FDB") and Medi-Span publish data sometimes called the Average Wholesale Price (AWP) of drugs. The AWP is often used as a factor in determining drug prices and can be used as a factor in determining some co-payments for the brand-name drugs at issue in the lawsuits.

The FDB-McKesson lawsuit claims that FDB and McKesson wrongfully inflated the mark-up factor used to determine the AWP of certain drugs. The Medi-Span lawsuit claims that Medi-Span negligently published the AWP price of certain prescription drugs based on information received from FDB.

As a result, some consumers and insurers allegedly overpaid for hundreds of drugs. FDB, McKesson, and Medi-Span deny any wrongdoing.

FDB and Medi-Span have separately agreed to settle their lawsuits and will pay a total of $1.5 million into a settlement fund to benefit a class of consumers and TPPs such as insurance companies, union health and welfare plans, and self-insured employers.

The proposed settlements also require FDB and Medi-Span to lower the mark-up factor used to determine the AWP for the drugs at issue in the lawsuits. As a result, plaintiffs believe a substantial decrease in drug costs may occur in the future.

Included in the FDB/Medi-Span proposed Settlements are consumers and TPPs that paid or reimbursed for all or a percentage of the cost of prescription drugs based on the AWP published by FDB from January 2000 to the present or the AWP published by Medi-Span from December 2001 to the present.

Consumers who paid a flat or fixed co-payment for the drugs are not included. Some Pharmacy Benefit Managers may not be included.

The McKesson Class Action includes consumers who paid percentage co-payments and TPPs that reimbursed for certain brand-name prescription drugs based on AWP pricing between August 1, 2001 and March 15, 2005 and whose co-payments or reimbursements were based on the AWP published by FDB or Medi-Span for the drugs.

Consumers who paid a flat or fixed dollar co-payment or are uninsured are not included.

Consumers and TPPs may remain in the FDB/Medi-Span proposed settlements or the McKesson Class Action by doing nothing, but they will be bound by the Court's rulings. Consumers and TPPs may also exclude themselves and keep their rights to sue FDB/Medi-Span and/or McKesson. Consumers and TPPs must exclude themselves in writing or via email by November 15, 2008.

The Court will determine whether to approve the FDB/Medi-Span proposed settlements at a Fairness Hearing on December 17, 2008 at 3 PM. For the McKesson Class Action, a trial is now set for December 1, 2008.

"The FDB/Medi-Span proposed settlements and the McKesson class action will hopefully allow consumers and TPPs to experience a savings in the future due to the anticipated decrease in drug costs," said Steve W. Berman of Hagens Berman Sobol Shapiro LLP, Counsel for the Plaintiffs.



Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.

Share

Follow us on Twitter.

FREE CONSUMER NEWSLETTERS

The Daily Consumer
Afternoons M-F

Sign up now!


Consumer News & Alerts
Every Sunday

Sign up now!





CONSUMER NEWS

SAFETY RECALLS

Back to the top |

Advertisement


Custom Search
AUTOMOTIVE
• Dealers
• Manufacturers
• Service
• Extended Warranties
• Lemon Laws
• Recalls
• Tires
• Transporters

FAMILY
• Aging
• Children, Parenting
• Recalls
• Dating
• Education
• Entertainment
• Pets
• Weddings
FINANCE
• Annuities
• Banks
• Credit Cards
• Debt Collection
• Debt Counseling
• Insurance
• Investing
• Loans
• Mortgages
• Payday Loans
• Student Loans
• Tax Prep

HEALTH
• Doctors
• Drugs, Pharmacies
• Health Clubs
• Hearing Care
• Hospitals
• Nursing Homes
• Nutrition, Diets
• Vision Care
• Weight Loss
HOUSE & HOME
• Appliances
• Cookware
• Furniture
• Home Improvements
• Lawn & Garden
• Movers
• Pools & Spas
• Realtors, Rental Agents
• Recalls
• Utilities

ELECTRONICS
• Cable TV/DBS
• Cameras
• Cell Phones
• Computers
• Home Electronics
• Internet Access
• Local Phone Service
• Long Distance
• VoIP
SHOPPING
• In-Home
• Online
• Retail Stores
• Sporting Goods
• Supermarkets
• Telemarketers

TRAVEL
• Airlines
• Bus Lines
• Car Rental
• Cruises
• Hotels
• Travel Agents
• Trains

RESOURCES
• Class Actions
• Complaint Form
• Small Claims Guide
• Lemon Laws
CONSUMER NEWS
• Latest News
• Automotive
• Telecom
• Financial
• Health
• Homeowners
• Scams
• Seniors
• Travel
• More ...

RECALLS
• Automotive
• Children's Products
• Drugs
• Food
• Household Products
• Sporting Goods

ABOUT US
• FAQ
• Privacy Policy
• Advertise With Us
• Newsroom
• Syndication
• Terms of Use

Terms of Use Your use of this site constitutes acceptance of the Terms of Use

Advertisements on this site are placed and controlled by outside advertising networks. ConsumerAffairs.com does not evaluate or endorse the products and services advertised. See the FAQ for more information.

Company Response Welcome If complaints about your company appear on our site, we welcome your response. Please see the Response Form for more information.

For more information, see the FAQ and privacy policy. The information on this Web site is general in nature and is not intended as a substitute for competent legal advice.  ConsumerAffairs.com Inc. makes no representation as to the accuracy of the information herein provided and assumes no liability for any damages or loss arising from the use thereof. 

Copyright © 2003-2009 ConsumerAffairs.com Inc.  All Rights Reserved.    The contents of this site may not be republished, reprinted, rewritten or recirculated without written permission.